Literature DB >> 24723206

Plasma anti-α-galactoside antibody binds to serine- and threonine-rich peptide sequence of apo(a) subunit in Lp(a).

M Geetha1, V Kalaivani, P S Sabarinath, P S Appukuttan.   

Abstract

Lipoprotein(a) immune complexes [Lp(a) IC] of varying particle density obtained by ultracentrifugation of plasma from normal healthy donors were markedly dominated by IgG. Lp(a) and immunoglobulins were liberated from plasma Lp(a) IC by treatment with melibiose, a sugar specific for circulating anti-α-galactoside antibody (anti-Gal). Upon incubation with plasma lipoprotein fraction anti-Gal but not the α-glucoside-specific antibody from human plasma formed de novo IC with Lp(a). Binding of Lp(a) sugar-reversibly enhanced the fluorescence of FITC-labeled anti-Gal as did binding of α-galactoside-containing glycoproteins. This effect apparently due to conformational shift in the Fc region of the antibody was also produced by apo(a) subunit separated from Lp(a) and de-O-glycosylated apo(a) but not by any other plasma lipoproteins or by Lp(a) pre-incubated with the O-glycan-specific lectin jacalin. O-Glycans and their terminal sialic acid moieties in apo(a) of circulating Lp(a)-anti-Gal IC, in contrast to those in pure Lp(a), were inaccessible to jacalin and anion exchange resin, respectively. Unlike other plasma lipoproteins, Lp(a) inhibited Griffonia simplicifolia isolectin B4 which also accommodates serine- and threonine-rich peptide sequence (STPS) as surrogate ligand to α-galactosides at its binding site. Results suggest that anti-Gal recognizes STPS in the O-glycan-rich regions of apo(a) subunit in Lp(a) which contains no α-linked galactose.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24723206     DOI: 10.1007/s10719-014-9521-2

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  31 in total

1.  Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.

Authors:  Kim M Wigglesworth; Waldemar J Racki; Rabinarayan Mishra; Eva Szomolanyi-Tsuda; Dale L Greiner; Uri Galili
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 3.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

4.  Lectin purification on affinity columns containing reductively aminated disaccharides.

Authors:  R J Baues; G R Gray
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

5.  Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease.

Authors:  Gregory T Jones; Andre M van Rij; Jennifer Cole; Michael J A Williams; Emma H Bateman; Santica M Marcovina; Meiying Deng; Sally P A McCormick
Journal:  Clin Chem       Date:  2007-02-15       Impact factor: 8.327

6.  Anti-GaL IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation.

Authors:  O P Minanov; S Itescu; F A Neethling; A S Morgenthau; P Kwiatkowski; D K Cooper; R E Michler
Journal:  Transplantation       Date:  1997-01-27       Impact factor: 4.939

7.  A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis.

Authors:  David E Mosedale; Anoop Chauhan; Peter M Schofield; David J Grainger
Journal:  J Immunol Methods       Date:  2006-01-03       Impact factor: 2.303

8.  apoB-independent enzyme immunoassay for lipoprotein(a) by capture on immobilized lectin (jacalin).

Authors:  Anuradha Sreekumar; Geetha Mandagini; Sabarinath P Subramanian; Appukuttan P Sankunni
Journal:  J Immunoassay Immunochem       Date:  2013

9.  Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora.

Authors:  U Galili; R E Mandrell; R M Hamadeh; S B Shohet; J M Griffiss
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

10.  Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.

Authors:  U Galili; M R Clark; S B Shohet; J Buehler; B A Macher
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more
  7 in total

1.  Antigen-Induced Activation of Antibody Measured by Fluorescence Enhancement of FITC Label at Fc.

Authors:  Genu George; Mandagini Geetha; Padinjaradath S Appukuttan
Journal:  J Fluoresc       Date:  2015-08-11       Impact factor: 2.217

2.  Activity of MUC1 cancer antigen-binding plasma anti-α-galactoside antibody correlates inversely with size of autologous lipoprotein(a).

Authors:  Jessy John; Vasantha Kalaivani; Mandagini Geetha; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2019-08

3.  Immunopathology of desialylation: human plasma lipoprotein(a) and circulating anti-carbohydrate antibodies form immune complexes that recognize host cells.

Authors:  P S Sabarinath; P S Appukuttan
Journal:  Mol Cell Biochem       Date:  2015-01-30       Impact factor: 3.396

4.  Circulating Lp(a):LDL complexes contain LDL molecules proportionate to Lp(a) size and bind to galectin-1: a possible route for LDL entry into cells.

Authors:  Vasantha Kalaivani; Padinjaradath Sankunni Appukuttan
Journal:  Lipids       Date:  2014-08-21       Impact factor: 1.880

5.  Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages.

Authors:  Binu Sheela; Genu George; Geetha Mandagini; Padinjaradath S Appukuttan
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

6.  Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

Authors:  Jessy John; Kurian Cherian; Thomas Abraham; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

7.  High glucose removes natural anti-α-galactoside and anti-β-glucoside antibody immune complexes adhering to surface O-glycoproteins of normal platelets and enhances platelet aggregation.

Authors:  Sreedevi Karthi; Sangeetha Sukumari-Ramesh; Mandagini Geetha; Padinjaradath Sankunni Appukuttan
Journal:  Exp Ther Med       Date:  2021-11-25       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.